Millions of Americans Have Undiagnosed Liver Disease

Millions of Americans Have Undiagnosed Liver Disease

Some 17 million people across the US, UK, Germany, and France are living with the most aggressive form of fatty liver disease and have no idea, a new study suggests. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe progression of a broader condition now known as metabolic dysfunction-associated steatotic liver disease...

Dietitian shares 2 fatty liver signs seen in clients as 15 million unknowingly live with 'aggressive form' of disease

More than 15 million people across the US, UK, Germany and France are unknowingly living with metabolic dysfunction-associated steatohepatitis (MASH), the most aggressive form of fatty liver disease, according to new research

Study finds new way to treat fatty liver disease

Fatty liver disease, especially a type called non-alcoholic fatty liver disease (NAFLD), is becoming a serious health problem across the world. It affects about one in four people, yet many don’t even know they have it. That’s because in the early stages, it usually doesn’t cause any symptoms. But if it’s not treated, it can […] The post Study finds new way to treat fatty liver disease appeared first on Knowridge Science Report.

Can Fatty Liver Be Reversed? Dr Wendi LeBrett Shares 4 Key Lifestyle Changes

Fatty liver disease, a condition marked by excess fat accumulation in the liver, can be reversed with the right lifestyle changes, according to Dr Wendi LeBrett, MD, a gastroenterologist. In a video shared on March 9, Dr Wendi explained the causes of fatty liver and outlined four steps to improve or even reverse the condition. Dr Wendi emphasized that the two primary causes of fatty liver are alcohol use and metabolic syndromes. “The first is a…

Hepatic encephalopathy: Improve diagnosis, management, and care

Hepatic encephalopathy (HE) is no longer a rare complication — it’s an urgent clinical reality that’s a leading cause of hospitalization in patients with cirrhosis1. HE can be deceptively subtle or profoundly severe, presenting with a wide clinical spectrum — from mild cognitive slowing to life-threatening coma. Without clear disease biomarkers, HE remains a diagnosis of exclusion, making it critical for clinicians to remain vigilant, especially…